Huang Dachuan

7PUBLICATIONS
60CO-AUTHORS
Cancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPeripheral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 02, 2026
Forging New Pathways in Oncology: Strategic Insights from the 17th Annual Frontiers in Cancer Science Conference.

|Oct 15, 2025
Priming with DNMT Inhibitors Potentiates PD-1 Immunotherapy by Triggering Viral Mimicry in Relapsed/Refractory NK/T-cell Lymphoma.

Cheng Huang, Yan Gao, Jianfeng Chen

|Oct 19, 2022
An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphoma.

Jasmine Goh, Sanjay De Mel, Michal M Hoppe

|Jul 16, 2020
PRDM15 is a key regulator of metabolism critical to sustain B-cell lymphomagenesis.

Slim Mzoughi, Jia Yi Fong, David Papadopoli

|Feb 01, 2020
Evaluation of the PIK3 pathway in peripheral T-cell lymphoma and NK/T-cell lymphoma.

Dachuan Huang, Tammy Linlin Song, Maarja-Liisa Nairismägi

|Jan 29, 2020
Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma.

Sanjay de Mel, Masturah B M Rashid, Xi Yun Zhang

Pageof 2

Frequent Collaborators

7 joint publications

Choon Kiat Ong

4 joint publications

Anand Jeyasekharan

2 joint publications

Burton Kuan Hui Chia

2 joint publications

Jing-Quan Lim